0001179110-20-001663.txt : 20200214 0001179110-20-001663.hdr.sgml : 20200214 20200214185319 ACCESSION NUMBER: 0001179110-20-001663 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200212 FILED AS OF DATE: 20200214 DATE AS OF CHANGE: 20200214 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WHEELER CRAIG A CENTRAL INDEX KEY: 0001229450 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50797 FILM NUMBER: 20622616 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MOMENTA PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001235010 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 043561634 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 301 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617 491-9700 MAIL ADDRESS: STREET 1: 301 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 edgar.xml FORM 4 - X0306 4 2020-02-12 0 0001235010 MOMENTA PHARMACEUTICALS INC MNTA 0001229450 WHEELER CRAIG A C/O MOMENTA PHARMACEUTICALS, INC. 301 BINNEY STREET CAMBRIDGE MA 02142 1 1 0 0 President & CEO Common Stock 2020-02-12 4 M 0 4581 13.26 A 18665 D Common Stock 2020-02-12 4 S 0 4581 32.01 D 14084 D Common Stock 2020-02-12 4 M 0 6172 A 20256 D Common Stock 2020-02-13 4 S 0 2778 30.82 D 17478 D Common Stock 36725 I Craig A Wheeler 2016 Annuity Trust Common Stock 48263 I Craig A Wheeler 2018 Annuity Trust Common Stock 419934 I Craig Wheeler Revocable Trust Restriced Stock Units 2020-02-12 4 A 0 6172 0 A Common Stock 6172 49375 D Stock Option (Right to Buy) 13.26 2020-02-12 4 A 0 4581 0 A 2014-02-22 2021-02-22 Common Stock 4581 21894 D This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2018. This transaction was executed in multiple trades at prices ranging from $32.00 to $32.06. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Shares received pursuant to settlement of Restricted Stock Units that were granted on February 12, 2018. Restricted Stock Units convert into common stock on a one-for-one basis. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2018. This transaction was executed in multiple trades at prices ranging from $29.57 to $31.67. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Each Restricted Stock Unit represents a contingent right to receive one share of MNTA common stock. Represents restricted stock granted by the issuer pursuant to the issuer's 2013 Incentive Award Plan, as amended and restated. Subject to the officer's continued employment with the company, the restricted stock units will vest with respect to 25% of the shares on the first anniversary of the grant date, and the remainder will vest in equal quarterly installments over the subsequent three years. Represents options granted by the issuer pursuant to the issuer's 2013 Incentive Award Plan, as amended and restated. /s/ R. Mark Chamberlin as attorney in fact 2020-02-14